This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
T

ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradigm

By 2024 ESMO Annual Meeting Insights Hub FEATURING Teresa Macarulla Mercade
By 2024 ESMO Annual Meeting Insights Hub FEATURING Teresa Macarulla Mercade
45 views
September 30, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

2024 ESMO Annual Meeting Insights Hub: GI Videos

13:22

New

ESMO 2024 Insights: Efficacy of 177Lu-DOTA-TATE in GEP-NETs - Multiv…

2024 ESMO Annual Meeting Insights Hub

D. Ferone

1 week ago
13:57

New

ESMO 2024 Summary: Optimal Sequencing of Therapeutic Strategies in I…

2024 ESMO Annual Meeting Insights Hub

T. André

23 views

·

2 weeks ago
18:22

New

ESMO 2024 Summary: Sequencing CRC Targeted Therapies Based on Biomar…

2024 ESMO Annual Meeting Insights Hub

L. Weiss

42 views

·

2 weeks ago
View All

Recommended

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views

·

8 months ago
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views

·

9 months ago
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

598 views

·

2 months ago
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

704 views

·

4 months ago
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

882 views

·

7 months ago
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

493 views

·

4 months ago
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

729 views

·

7 months ago
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

456 views

·

4 months ago
21:51

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

MyCancerHaven

R. Vij, G. Murthy

554 views

·

2 months ago
28:02

2024 Updates in AML

University of Colorado Division of Hematology

C. McMahon

732 views

·

7 months ago
22:30

Emerging Treatment Options for AML in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Perl

697 views

·

8 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

883 views

·

7 months ago
09:51

MRD Testing in Leukemias: When Negativity Is a Positive Thing

i3 Health

N. S. Raje

465 views

·

8 months ago
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

419 views

·

1 month ago
02:01

Administration and Dosing of Tagraxofusp for BPDCN

Emanuele Angelucci

336 views

·

3 months ago
34:57

BPDCN: Current and Future Directions

Icahn School of Medicine at Mount Sinai

N. Pemmaraju

455 views

·

5 months ago
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

395 views

·

5 months ago
11:35

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Vanderbilt University Medical Center (VUMC)

A. Jallouk

253 views

·

4 months ago
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

409 views

·

5 months ago
14:39

Immunotherapies in Acute Leukemias: 2024 Update

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

C. Lai

503 views

·

8 months ago
AUTOPLAY